Pharvaris
Jonathan Levy holds a Doctor of Philosophy degree in Biostatistics from UC Berkeley Graduate School of Public Health. With over three decades of experience, Jonathan has worked as a Senior Statistical Scientist at Genentech and currently serves as the Associate Director of Biostatistics at Pharvaris. Jonathan also holds a Bachelor of Science in Mathematics from Wesleyan University and a Master of Science from Tulane University.
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.